ADVERTISEMENT

Aurobindo Pharma Ends At One-Month High On Best Revenue, Ebitda In Two Years

Aurobindo Pharma’s revenue rose 15.8% year-on-year to Rs 6,483.4 crore in the quarter ended September.

A man rides past an Aurobindo Pharma production facility in Jadcherla, India. (Photographer: Prashanth Vishwanathan/Bloomberg)
A man rides past an Aurobindo Pharma production facility in Jadcherla, India. (Photographer: Prashanth Vishwanathan/Bloomberg)

Shares of Aurobindo Pharma Ltd. rose to the highest in a month after the Hyderabad-based drugmaker reported its best quarterly revenue and operating profit in at least two years.

The company’s revenue rose 15.8% year-on-year to Rs 6,483.4 crore in the quarter ended September, the highest in at least eight quarters, according to an exchange filing. That compares with the Rs 6,218-crore consensus estimate of analysts tracked by Bloomberg.

Its net profit rose 26% over the year earlier to Rs 806.2 crore, against Rs 778 crore forecast.